L11: Transplantation Immunology Flashcards
Types of transplantation grafts
- ) Autologous graft – individual to same individual
- ) Syngeneic graft – bw two genetically identical individuals (identical twins)
- ) Allogeneic graft – bw two genetically dissimilar individuals (from same species
- ) Xenogeneic graft – bw members of two different species
Orthotic vs heterotopic transplant
- Orthotic = graft placed in its normal anatomic location
- Heterotopic = graft placed in anatomically different site
What is meant by immunologically privileged site? What mechanisms confer privilege?
- Locations where allogenic transplants can be placed without risk of rejection – ant chamber of eye, cornea, testes, brain
1. ) ECF bathing tissue doesn’t leave through conventional lymph
2. ) TGF-beta (inhibitory) produced
3. ) Fas-ligand reacts with Fas on lymphocytes to induce apoptosis
What is sympathetic opthalmia?
- Following damaged to one eye by trauma, an autoimmune response to eye proteins develop and threatens undamaged eye
True / False. Grafts derived from children will be rejected by either parent
- True
What is the genetic basis of transplant rejection?
- Class I and II MHC proteins perceived as foreign d/t polymorphic expression and education of thymocytes (positive selection)
Types of graft rejections following transplant. Note timeframe and mechanism that mediates this.
- ) Hyperacute rejection: minutes (incl on OR table), mediated by pre-existing antibodies (eg. Anti-ABO blood group)
- ) Acute rejection: within 1 month, two types: 1.) acute humoral rejection (ab and complement-mediate lysis of graft tissue leading to necrosis of blood vessel walls) and 2.) acute cellular rejection (cell-mediated lysis of graft tissue by CTLs, NK cells and macrophages)
- ) Chronic rejection: months to years after transplant, may involve ab-mediated injury or type IV hypersensitivity, characterized by fibrosis and deposition of collagen resulting in vascular occlusion
Of the 3 types of graft rejections following transplantation, which can be treated?
- Acute rejection
T cells require antigen and self MHC proteins in order to become activated. How to allografts activate T cells?
- One option could be that recipient APCs present foreign peptides in conjunction with self class II MHC to activate T-helper cells.
- Answer = alloreactivity = foreign MHC proteins are recognized d/t polymorphic AAs on MHC that mimich conformation of both self MHC and foreign peptide.
What is alloreactivity? Describe activation of T cells using this mechanism
- Recognition of foreign MHC proteins by TCR d/t polymorphic AAs on MHC mimic conformation of self MHC loaded with foreign peptide
1. ) Donor and recipient DCs present alloantigens, which stimulates CD4+ T cells to become activated
2. ) CD4+ cells provide IFN-gamma and IL-2 to alloreactive CD8+ T cells to produce CTLs that lyse graft cells, alloreactive B cells produce anti-graft antibodies
Strategies to prevent transplant rejection
1.) Select most compatible graft (class I and II MHC similarity)
- ) Immunosuppresion:
a. ) corticosteroids: lyse immature thymocytes, block release of cytokines from macrophages and inhibit leukocyte migration
b. ) cyclosporine: inhibits IL-2 and IFN-gamma expression preventing activation of cell-mediated immunity
c. ) anti-lymphocyte globulin (from horse serum): kills wanted and unwanted lymphocytes, but can reverse acute graft rejection (side effect = serum sickness)
d. ) anti-IL-2R
e. ) anti-TCR
f. ) azathioprine, mycophenolate, rapamycin
3.) depletion of passenger leukocytes from graft can eliminate or delay graft rejection
Function of corticosteroids in transplant rejection
- lyse immature thymocytes, block release of cytokines from macrophages and inhibit leukocyte migration
Function of cyclosporine in transplant rejection
- inhibits IL-2 and IFN-gamma expression preventing activation of cell-mediated immunity
- allows for maintenance of memory response, just knocks off primary immune response
Function of anti-lymphocyte globulin in transplant rejection
- anti-lymphocyte globulin (from horse serum): kills wanted and unwanted lymphocytes, but can reverse acute graft rejection (side effect = serum sickness)
What is GVDH? Types? Treatment?
- Graft-versus-host disease
- Disease following bone marrow donation
- 1.) acute = epithelial cell necrosis of skin, liver and GI – can be fatal if severe
- 2.) chronic = fibrosis in organs causing dysfunction – fatal if severely affects critical organs
- Treatment: anti-CD3 mab